ArticleOncotarget2017

Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma.

Qing-Yun Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.